Building on the collective strength of industry leaders committed to advancing obesity care and support, the OAC’s Corporate Council continues to grow as we welcome new and returning members who share our vision for a better for individuals affected by obesity. We’re honored to recognize the following companies for participating in OAC’s level of membership:
Read Article

FOR IMMEDIATE RELEASE: Tampa, FL — October 18, 2024 — This Thanksgiving week, the Obesity Action Coalition (OAC) extends its gratitude to the Biden Administration for proposing a new rule significantly expanding access to obesity medications for Americans with Medicare and Medicaid coverage. “This is incredible. For more than a decade, the OAC, alongside partner
Read Article

The conversation around GLP-1 medications has grown louder in recent years, with these treatments showing great promise for managing obesity. However, challenges like supply shortages and affordability have created barriers for many individuals. In response, patients are turning to compounded GLP-1 medications as an alternative. Leading Conversations on GLP-1 Compounding At the Obesity Action Coalition
Read Article

ObesityWeek 2024 in San Antonio brought together more than 3,200 attendees to explore the latest science and policies around obesity. The OAC had the privilege of attending this esteemed conference once again, and we hosted a booth that engaged attendees with information about our mission, advocacy efforts and upcoming initiatives. Our new Stop Weight Bias
Read Article

The 2025 Open Enrollment period for many healthcare plans, including private insurance, Affordable Care Act (ACA) plans, Medicare and Medicaid, is now underway. Open Enrollment happens annually, giving you the chance to review your insurance coverage and make sure it meets your current healthcare needs. During this time, you can enroll in, re-enroll in, or
Read Article

At HLTH 2024, the Obesity Action Coalition (OAC) unveiled its new bias-free obesity image gallery with the support of Eli Lilly and Company (Lilly). In a new interview with Lilly’s Jamie Coleman, Vice President, Brand Marketing, US Obesity, and OAC’s James Zervios, Chief Operating Officer, we explore why this image gallery was developed and the need
Read Article